ReviewTherapeutic advances in musculoskeletal disease2022

The role of antifibrotic therapies in the treatment of systemic sclerosis-associated interstitial lung disease.

Gonçalo Boleto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.